A Pilot/Phase 1, Interventional, Open-label, Multi-center Study to Assess the Safety and Efficacy of L-glutamine Treatment in Patients With Diverticulosis
Latest Information Update: 18 Feb 2023
At a glance
- Drugs Glutamine (Primary)
- Indications Diverticulitis
- Focus Therapeutic Use
- Sponsors Emmaus Medical
- 15 Feb 2023 Status changed from active, no longer recruiting to completed.
- 25 Jul 2022 Planned End Date changed from 30 Jun 2022 to 31 Dec 2022.
- 25 Jul 2022 Planned primary completion date changed from 31 May 2022 to 30 Oct 2022.